Helsinn announces pu
Helsinn announces publication of new data evaluating impact of NEPA (netupitant/palonosetron) on hospital costs
February 03, 2023 08:00 ET | Helsinn
Helsinn announces publication of new data evaluating impact of NEPA (netupitant/palonosetron) on hospital costs Lugano, Switzerland, February 3, 2023 - Helsinn Group (“Helsinn”), a fully integrated...
logo.jpg
Helsinn announces the appointment of Dr Melanie Rolli as Group Chief Executive Officer
January 09, 2023 08:00 ET | Helsinn Healthcare S.A.
Helsinn announces the appointment of Dr Melanie Rolli as Group Chief Executive Officer - Giorgio Calderari appointed Vice Chairman of the Board Lugano, Switzerland, January 9, 2023 - Helsinn Group...
logo.jpg
Helsinn announces presentation on CINV trial at European Society for Medical Oncology (ESMO) Asia
November 29, 2022 08:00 ET | Helsinn Healthcare S.A.
Helsinn announces presentation on CINV trial at European Society for Medical Oncology (ESMO) Asia Lugano, Switzerland, November 29, 2022 - Helsinn Group (“Helsinn”), a fully integrated global...
logo.jpg
Farma Mondo Group and Helsinn sign exclusive partnership to commercialize AKYNZEO® in the Baltic region
November 28, 2022 06:00 ET | Helsinn Healthcare S.A.
Farma Mondo Group and Helsinn sign exclusive partnership to commercialize AKYNZEO® in the Baltic region CHIASSO, Switzerland and LUGANO, Switzerland – November 28, 2022 – Farma Mondo Group, a...
logo.jpg
Helsinn presents novel data on Chlormethine gel at EORTC cutaneous lymphomas tumors group annual meeting
September 21, 2022 08:34 ET | Helsinn Healthcare S.A.
Helsinn presents novel data on Chlormethine gel at EORTC cutaneous lymphomas tumors group annual meeting Data on chlormethine in both clinical trials and real-world settings will be presentedHelsinn...
logo.jpg
Helsinn presents newly available data on vepafestinib at IASLC 2022 World Conference on Lung Cancer
August 08, 2022 04:07 ET | Helsinn Healthcare S.A.
Helsinn presents newly available data on vepafestinib at IASLC 2022 World Conference on Lung Cancer Lugano, Switzerland, August 8, 2022 - Helsinn Group (“Helsinn”), a fully integrated, global...